Materias dentro de su búsqueda.
Mostrando 1,221 - 1,240 Resultados de 1,240 Para Buscar '"director general"', tiempo de consulta: 2.86s Limitar resultados
  1. 1221
    “…ETHICS AND DISSEMINATION: The protocol was reviewed and approved by the International Centre for Diarrhoeal Disease Research, Bangladesh Research Review Committee and Ethical Review Committee, and the Directorate General of Drug Administration in Bangladesh, and by the Regional Ethics Committee in Norway. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh
  2. 1222
    “…Various risk governance strategies and inclusion of modern technologies paved the way for better and efficient public health emergency management of COVID-19 pandemic, effort being made by State government to scale up the team up to 1 lakh for effective surveillance on COVID-19. UP Directorate General of Medical and Health services demarcated the health facilities as L1, L1 Covid Care Center, L2, and L3 throughout the state for treatment, depending on their capacity and beds availability. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Uttar Pradesh: state governance and response in COVID-19 pandemic
  3. 1223
    “…In order to timely track deaths, the Portuguese Directorate-General of Health developed a deep neural network that codifies ICD-10 causes of death (AUTOCOD) by analyzing free text in a death certificate (DC). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Real-time classification of causes death using Artificial Intelligence – sensitivity analysis
  4. 1224
    “…Physicians in the control group had access to guidelines through the Directorate-General for Health’s website (passive dissemination). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of educational outreach visits compared with usual guideline dissemination to improve family physician prescribing—an 18-month open cluster-randomized trial
  5. 1225
    “…FUNDING SOURCES: Funding in research is supported by Directorate General of Higher Education, Research, and Technology, Ministry of Education, Culture, Research, and Technology of the Republic of Indonesia.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of Moringa Oliefera Supplementation During Pregnancy on Nutritional Status in Children 2–5 Years Old in Indonesia: A-Follow-Up Study
  6. 1226
    “…DESCRIPTION OF THE PROBLEM: The Portuguese Directorate-General of Health developed two evidence-based digital tools to support PA promotion by healthcare professionals: a) PA brief assessment tool; and b) brief counselling tool. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    O1-5 Digital tools for physical activity assessment and brief counselling in Primary Health Care: The Portuguese model
  7. 1227
    “…To raise the profile of physical activity (PA) among adults, the Portuguese National Physical Activity Promotion Program of the Directorate-General of Health developed and implemented a national mass media campaign in 2019 named ?…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    O3-2 Evaluation of implementation and impact of a national mass media campaign to promote active lifestyles in Portugal: ‘Follow the Whistle: Physical Activity is Calling You'
  8. 1228
    “…MATERIALS AND METHODS: The data for this study were collected at Prison in Lisbon District (Portugal) between 2017-2019 after prior approval of the Directorate General for Reinsertion and Prison Services (DGRSP). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Preliminary validation of bumby RAPE and MOLEST scales: Exploratory factorial analysis
  9. 1229
    “…Datasets were used from NASA for meteorological parameters, and daily DENV cases were obtained from the Directorate General of Health Service (DGHS) open-access websites. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correlation of Dengue and Meteorological Factors in Bangladesh: A Public Health Concern
  10. 1230
    “…Television was the main source of information used to clarify these doubts (32.9%), followed by a guideline issued by the Directorate-General of Health (30.7%). However, most respondents (50.9%) said that they had only found answers to some of their questions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Access to Information, and Concerns, Myths and Truths about Food Safety during the COVID-19 Pandemic: An Overview of the Portuguese Population
  11. 1231
    “…The study was carried out to examine the in vitro quality control tests for ten leading brands of ciprofloxacin hydrochloride 500 mg tablet formulation, registered in Bangladesh by Directorate General of Drug Administration. The quality control parameters of ten different brands of ciprofloxacin hydrochloride 500 mg tablets were determined by weight variation, friability, hardness, disintegration, dissolution and assay tests. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh
  12. 1232
    “…In this work, only the first pillar of the PBM model issue by Directorate-General for Health (DGS) was evaluated, which involves optimising Hb in the preoperative period with iron treatment if it’s necessary/indicated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical, economical and safety impact of ferric carboxymaltose use in Patient Blood Management programme in Portuguese National Health Service hospitals
  13. 1233
    “…The participants were divided into 2 groups, depending on the vitD status (sufficiency and insufficiency [≥20 ng/mL]; deficiency [<20 ng/mL]), and in 3 groups of clinical severity of RI (adapted from the update [14/10/2020] of the standard 004/2020 of the Portuguese Directorate-General for Health): mild/moderate disease (g1); severe disease without bacterial coinfection (g2); severe disease with bacterial coinfection/critical disease (g3). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Influence of Vitamin D Status on the Severity of SARS-CoV-2 Respiratory Infection
  14. 1234
    “…FUNDING: The study was funded by Dompé Farmaceutici SpA and supported by the funds from the European Commission – Health and Consumers Directorate General, for the Action under the Emergency Support Instrument- Grant to support clinical testing of repurposed medicines to treat SARS-COV-2 patients (PPPA-ESI-CTRM-2020-SI2.837140), and by the COVID-2020–12,371,675 Ricerca finalizzata and line 1 Ricerca Corrente COVID both funded by Italian Ministry of Health.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19
  15. 1235
    “…While the live-attenuated was more efficacious than the inactivated vaccine in children, many vaccine types can be used in adults and the elderly. FUNDING: The directorate general of welfare, Lombardy region.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparative efficacy and safety of vaccines to prevent seasonal influenza: A systematic review and network meta-analysis
  16. 1236
    “…FUNDING: UK Medical Research Council, Cancer Research UK, British Heart Foundation, International Agency for Research on Cancer, and European Commission Directorate-General for Research.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Alcohol and cause-specific mortality in Russia: a retrospective case–control study of 48 557 adult deaths
  17. 1237
    “…FUNDING: TB Alliance, UK Department for International Development, Bill & Melinda Gates Foundation, US Agency for International Development, Directorate General for International Cooperation of the Netherlands, Irish Aid, Australia Department of Foreign Affairs and Trade, and the Federal Ministry for Education and Research of Germany.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
  18. 1238
    “…Dr., Abbott: Honoraria|Abbvie: Advisor/Consultant|Actelion: Board Member|Al-Jazeera Pharmaceuticals: Honoraria|Allecra Therapeutics: Board Member|Amplyx: Advisor/Consultant|Amplyx: Grant/Research Support|Astellas: Honoraria|Basilea: Advisor/Consultant|Basilea: Grant/Research Support|Biocon: Advisor/Consultant|Biosys: Advisor/Consultant|BMBF: Grant/Research Support|Cidara: Advisor/Consultant|Cidara: Board Member|Cidara: Expert Testimony|Cidara: Grant/Research Support|CoRe Consulting: Stocks/Bonds|Da Volterra: Advisor/Consultant|DLR: Grant/Research Support|DZIF: Grant/Research Support|Entasis: Board Member|EU Directorate-General for Resarch and Innovation: Grant/Research Support|F2G: Grant/Research Support|German Patent and Trade Mark Office: German patent (DE 10 2021 113 007.7)|Gilead: Advisor/Consultant|Gilead: Grant/Research Support|Grupo Biotoscana/United Medical/Knight: Honoraria|Hikma: Honoraria|IQVIA: Board Member|Janssen: Board Member|Matinas: Advisor/Consultant|Matinas: Grant/Research Support|MedPace: Advisor/Consultant|MedPace: Grant/Research Support|MedScape: Honoraria|MedUpdate: Honoraria|Menarini: Advisor/Consultant|Merck/MSD: Grant/Research Support|Merck/MSD: Honoraria|Molecular Partners: Advisor/Consultant|MSG-ERC: Advisor/Consultant|Mundipharma: Grant/Research Support|Mylan: Honoraria|Noxxon: Advisor/Consultant|Octapharma: Advisor/Consultant|Octapharma: Grant/Research Support|Paratek: Board Member|Pardes: Advisor/Consultant|Pfizer: Grant/Research Support|Pfizer: Honoraria|Projektträger Jülich: Grant/Research Support|PSI: Advisor/Consultant|PSI: Board Member|Pulmocide: Board Member|Scynexis: Advisor/Consultant|Scynexis: Grant/Research Support|Seres: Advisor/Consultant|Shionogi: Board Member|Wiley (Blackwell): Editor-in-Chief, Mycoses.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    753. Guideline Adherence Predicts Outcomes of Candidemia in Europe: Results from the ECMM Candida III Multinational European study
  19. 1239
    por Sherratt, Katharine, Gruson, Hugo, Grah, Rok, Johnson, Helen, Niehus, Rene, Prasse, Bastian, Sandmann, Frank, Deuschel, Jannik, Wolffram, Daniel, Abbott, Sam, Ullrich, Alexander, Gibson, Graham, Ray, Evan L, Reich, Nicholas G, Sheldon, Daniel, Wang, Yijin, Wattanachit, Nutcha, Wang, Lijing, Trnka, Jan, Obozinski, Guillaume, Sun, Tao, Thanou, Dorina, Pottier, Loic, Krymova, Ekaterina, Meinke, Jan H, Barbarossa, Maria Vittoria, Leithauser, Neele, Mohring, Jan, Schneider, Johanna, Wlazlo, Jaroslaw, Fuhrmann, Jan, Lange, Berit, Rodiah, Isti, Baccam, Prasith, Gurung, Heidi, Stage, Steven, Suchoski, Bradley, Budzinski, Jozef, Walraven, Robert, Villanueva, Inmaculada, Tucek, Vit, Smid, Martin, Zajicek, Milan, Perez Alvarez, Cesar, Reina, Borja, Bosse, Nikos I, Meakin, Sophie R, Castro, Lauren, Fairchild, Geoffrey, Michaud, Isaac, Osthus, Dave, Alaimo Di Loro, Pierfrancesco, Maruotti, Antonello, Eclerova, Veronika, Kraus, Andrea, Kraus, David, Pribylova, Lenka, Dimitris, Bertsimas, Li, Michael Lingzhi, Saksham, Soni, Dehning, Jonas, Mohr, Sebastian, Priesemann, Viola, Redlarski, Grzegorz, Bejar, Benjamin, Ardenghi, Giovanni, Parolini, Nicola, Ziarelli, Giovanni, Bock, Wolfgang, Heyder, Stefan, Hotz, Thomas, Singh, David E, Guzman-Merino, Miguel, Aznarte, Jose L, Morina, David, Alonso, Sergio, Alvarez, Enric, Lopez, Daniel, Prats, Clara, Burgard, Jan Pablo, Rodloff, Arne, Zimmermann, Tom, Kuhlmann, Alexander, Zibert, Janez, Pennoni, Fulvia, Divino, Fabio, Catala, Marti, Lovison, Gianfranco, Giudici, Paolo, Tarantino, Barbara, Bartolucci, Francesco, Jona Lasinio, Giovanna, Mingione, Marco, Farcomeni, Alessio, Srivastava, Ajitesh, Montero-Manso, Pablo, Adiga, Aniruddha, Hurt, Benjamin, Lewis, Bryan, Marathe, Madhav, Porebski, Przemyslaw, Venkatramanan, Srinivasan, Bartczuk, Rafal P, Dreger, Filip, Gambin, Anna, Gogolewski, Krzysztof, Gruziel-Slomka, Magdalena, Krupa, Bartosz, Moszyński, Antoni, Niedzielewski, Karol, Nowosielski, Jedrzej, Radwan, Maciej, Rakowski, Franciszek, Semeniuk, Marcin, Szczurek, Ewa, Zielinski, Jakub, Kisielewski, Jan, Pabjan, Barbara, Holger, Kirsten, Kheifetz, Yuri, Scholz, Markus, Przemyslaw, Biecek, Bodych, Marcin, Filinski, Maciej, Idzikowski, Radoslaw, Krueger, Tyll, Ozanski, Tomasz, Bracher, Johannes, Funk, Sebastian
    Publicado 2023
    “…CP, DL, EA, MC, SA funded by European Commission - Directorate-General for Communications Networks, Content and Technology through the contract LC-01485746, and Ministerio de Ciencia, Innovacion y Universidades and FEDER, with the project PGC2018-095456-B-I00. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations
  20. 1240
    “…Dr., Abbott: Honoraria|Abbvie: Advisor/Consultant|Actelion: Board Member|Al-Jazeera Pharmaceuticals: Honoraria|Allecra Therapeutics: Board Member|Amplyx: Advisor/Consultant|Amplyx: Grant/Research Support|Astellas: Honoraria|Basilea: Advisor/Consultant|Basilea: Grant/Research Support|Biocon: Advisor/Consultant|Biosys: Advisor/Consultant|BMBF: Grant/Research Support|Cidara: Advisor/Consultant|Cidara: Board Member|Cidara: Expert Testimony|Cidara: Grant/Research Support|CoRe Consulting: Stocks/Bonds|Da Volterra: Advisor/Consultant|DLR: Grant/Research Support|DZIF: Grant/Research Support|Entasis: Board Member|EU Directorate-General for Resarch and Innovation: Grant/Research Support|F2G: Grant/Research Support|German Patent and Trade Mark Office: German patent (DE 10 2021 113 007.7)|Gilead: Advisor/Consultant|Gilead: Grant/Research Support|Grupo Biotoscana/United Medical/Knight: Honoraria|Hikma: Honoraria|IQVIA: Board Member|Janssen: Board Member|Matinas: Advisor/Consultant|Matinas: Grant/Research Support|MedPace: Advisor/Consultant|MedPace: Grant/Research Support|MedScape: Honoraria|MedUpdate: Honoraria|Menarini: Advisor/Consultant|Merck/MSD: Grant/Research Support|Merck/MSD: Honoraria|Molecular Partners: Advisor/Consultant|MSG-ERC: Advisor/Consultant|Mundipharma: Grant/Research Support|Mylan: Honoraria|Noxxon: Advisor/Consultant|Octapharma: Advisor/Consultant|Octapharma: Grant/Research Support|Paratek: Board Member|Pardes: Advisor/Consultant|Pfizer: Grant/Research Support|Pfizer: Honoraria|Projektträger Jülich: Grant/Research Support|PSI: Advisor/Consultant|PSI: Board Member|Pulmocide: Board Member|Scynexis: Advisor/Consultant|Scynexis: Grant/Research Support|Seres: Advisor/Consultant|Shionogi: Board Member|Wiley (Blackwell): Editor-in-Chief, Mycoses Kevin W. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    221. Assessment and Proposed Revision of Clinical Trial Clostridioides difficile Infection Clinical Response and Outcomes Definitions
Herramientas de búsqueda: RSS